Literature DB >> 33083910

The use of 2-, 5-, and 10-year probabilities to characterize fracture risk after a recent sentinel fracture.

J A Kanis1,2, H Johansson3,4, N C Harvey5,6, V Gudnason7,8, G Sigurdsson7, K Siggeirsdottir7, M Lorentzon3,9, E Liu3, L Vandenput3,10, W D Leslie11, E V McCloskey4,12.   

Abstract

The increase in fracture risk associated with a recent fragility fracture is more appropriately captured using a 10-year fracture probability than 2- or 5-year probabilities.
INTRODUCTION: The recency of prior fractures affects subsequent fracture risk. The aim of this study was to quantify the effect of a recent sentinel fracture, by site, on the 2-, 5-, and 10-year probability of fracture.
METHODS: The study used data from the Reykjavik Study fracture register that documented prospectively all fractures at all skeletal sites in a large sample of the population of Iceland. Fracture probabilities were determined after a sentinel fracture (humeral, clinical vertebral, forearm and hip fracture) occurring within the previous 2 years and probabilities for a prior osteoporotic fracture irrespective of recency. The probability ratios were used to adjust fracture probabilities over a 2-, 5-, and 10-year time horizon.
RESULTS: As expected, probabilities decreased with decreasing time horizon. Probability ratios varied according to age and the site of sentinel fracture. Probability ratios to adjust for a prior fracture within the previous 2 years were higher the shorter the time horizon, but the absolute increases in fracture probabilities were much reduced. Thus, fracture probabilities were substantially lower with time horizons less than 10 years.
CONCLUSION: The 10-year probability of fractures is the appropriate metric to capture the impact of the recency of sentinel fractures. The probability ratios provide adjustments to conventional FRAX estimates of fracture probability for recent sentinel fractures, adjustments which can readily inform clinical decision-making.

Entities:  

Keywords:  FRAX adjustment; Fracture probability; Imminent risk; Prior fracture; Risk assessment; Sentinel fracture

Mesh:

Year:  2020        PMID: 33083910     DOI: 10.1007/s00198-020-05700-w

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   5.071


  2 in total

Review 1.  A systematic review of intervention thresholds based on FRAX : A report prepared for the National Osteoporosis Guideline Group and the International Osteoporosis Foundation.

Authors:  John A Kanis; Nicholas C Harvey; Cyrus Cooper; Helena Johansson; Anders Odén; Eugene V McCloskey
Journal:  Arch Osteoporos       Date:  2016-07-27       Impact factor: 2.617

2.  Worldwide uptake of FRAX.

Authors:  J A Kanis; H Johansson; A Oden; C Cooper; E V McCloskey
Journal:  Arch Osteoporos       Date:  2014-01-14       Impact factor: 2.617

  2 in total
  6 in total

1.  Prediction of imminent fracture risk in Canadian women and men aged 45 years or older: external validation of the Fracture Risk Evaluation Model (FREM).

Authors:  Sören Möller; Michael K Skjødt; Lin Yan; Bo Abrahamsen; Lisa M Lix; Eugene V McCloskey; Helena Johansson; Nicholas C Harvey; John A Kanis; Katrine Hass Rubin; William D Leslie
Journal:  Osteoporos Int       Date:  2021-10-01       Impact factor: 4.507

2.  Implications of FRAX® adjusted for recent fracture on the indication of treatment in an FLS.

Authors:  Antonio Naranjo; Amparo Molina; Carlos Rodríguez-Lozano; Rubén López; Sonia Fuentes; Soledad Ojeda
Journal:  Arch Osteoporos       Date:  2022-08-15       Impact factor: 2.879

3.  Osteoporosis management and secondary fragility fracture rates in patients with multiple sclerosis: a matched cohort study.

Authors:  Bailey J Ross; Austin J Ross; Olivia C Lee; Timothy L Waters; McCayn M Familia; William F Sherman
Journal:  Osteoporos Int       Date:  2022-06-07       Impact factor: 5.071

Review 4.  UK clinical guideline for the prevention and treatment of osteoporosis.

Authors:  Celia L Gregson; David J Armstrong; Jean Bowden; Cyrus Cooper; John Edwards; Neil J L Gittoes; Nicholas Harvey; John Kanis; Sarah Leyland; Rebecca Low; Eugene McCloskey; Katie Moss; Jane Parker; Zoe Paskins; Kenneth Poole; David M Reid; Mike Stone; Julia Thomson; Nic Vine; Juliet Compston
Journal:  Arch Osteoporos       Date:  2022-04-05       Impact factor: 2.879

Review 5.  Management of patients at very high risk of osteoporotic fractures through sequential treatments.

Authors:  Elizabeth M Curtis; Jean-Yves Reginster; Nasser Al-Daghri; Emmanuel Biver; Maria Luisa Brandi; Etienne Cavalier; Peyman Hadji; Philippe Halbout; Nicholas C Harvey; Mickaël Hiligsmann; M Kassim Javaid; John A Kanis; Jean-Marc Kaufman; Olivier Lamy; Radmila Matijevic; Adolfo Diez Perez; Régis Pierre Radermecker; Mário Miguel Rosa; Thierry Thomas; Friederike Thomasius; Mila Vlaskovska; René Rizzoli; Cyrus Cooper
Journal:  Aging Clin Exp Res       Date:  2022-03-24       Impact factor: 4.481

6.  Long-Term Treatment of Postmenopausal Osteoporosis.

Authors:  Jacques P Brown
Journal:  Endocrinol Metab (Seoul)       Date:  2021-06-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.